55,58 However, postmarketing data on exenatide indicate an increase in INR, which is sometimes associated with bleeding events, highlighting the need for close INR monitoring after GLP-1 RA treatment
The decision to escalate to maximum dose should be made carefully between you and your provider, weighing results achieved at lower doses against the increased side effect burden
Not recommended for pregnant and breastfeeding women, children and adolescents, people with autoimmune conditions, epilepsy, asthma, mood, behavior or personality disorders, as well as people undergoing medical treatment
Michael manages the business operations, growth strategy, and community partnerships that allow the clinic to thrive
Getting a science reporter to do that dismissing for you is even better than lobbying, because it comes with a press badge